Use the table below, summarized from CFO Magazine’s 2006 working capital survey to answer this question. Compare Genzyme’s CCC to that of Quest Diagnostics. What do the CCC for the two companies tell us about their working capital management? Why is Genzyme’s 2005 CCC different from Quest’s? Suppose that Genzyme’s annual sales are $2,734,842,000 and its cost of capital is 15%. If Genzyme’s CCC drops to the level of Quests’s, how much savings will Genzyme generate in net working capital and what is the annual benefit of this savings in dollars?